A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $28 to $33
Pfizer (PFE) Gets a Hold From J.P. Morgan
Cautious Outlook: Pfizer's EPS Downgrade and Conservative Guidance Prompt Hold Rating
Pfizer Is Maintained at Buy by Guggenheim
Pfizer Analyst Ratings
Pfizer (PFE) Gets a Buy From Evercore ISI
Guggenheim Adjusts Price Target on Pfizer to $33 From $35, Keeps Buy Rating
Pfizer Analyst Ratings
B of A Securities Reinstates Neutral on Pfizer, Announces $29 Price Target
Berenberg Bank Maintains Pfizer(PFE.US) With Hold Rating, Raises Target Price to $29
Berenberg Bank Sticks to Their Hold Rating for Pfizer (PFE)
Morgan Stanley Sticks to Their Hold Rating for Pfizer (PFE)
Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31
Leerink Partners Maintains Pfizer(PFE.US) With Hold Rating
Wolfe Research Initiates Pfizer at Underperform With $25 Price Target
Pfizer Analyst Ratings
Wolfe Research Downgrades Pfizer(PFE.US) to Sell Rating, Announces Target Price $25
Pfizer Initiated With an Underperform at Wolfe Research
UBS Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31
UBS Remains a Hold on Pfizer (PFE)